Who Attends?

Who Attends?

The TPD Summit provides an unrivalled opportunity to network with KOLs and pioneers as well as helping you stay ahead of the curve by focusing on optimizing target validation, improving medicinal chemistry and ultimately accelerating the translation of selective, bioavailable and effective protein degraders into clinical trials.

If you are or want to become a player in the protein degradation arena, this is the meeting that you should attend to engage in meaningful discussions with 470+ pharmaceutical, biotech and translational researchers at the forefront of this growing field that will help drive forward your TPD strategies across all proteome targets and therapeutic indications.

Industry
Seniority

*Based on the TPD Summit 2019

2020 Attendees Included:

2020 attendees per